Suven Life Science Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA-72-1170
EBIT-77-1210
Earning Per Share-5-9-7
Expenses94134139
Net Profit-72-122-118
Net Profit Margin-535-1,030-874
Operating Profit Margin-537-988-867
Profit Before Tax-77-122-118
Dividends Per Share000
Operation Revenue211722

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
20221,739.202,486.90993.609,042.131,441.20
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Suven Life Science is 0 as of 2/26/2024
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212022
Operating Activities70-53-135-96-128
Investing Activities-13714656-22
Financing Activities-525335146
Others00000
Net Cash Flow17-1114-5-4

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2021-2.18-34.87-15.36-52.41
2023625.39-528.49-77.4619.45
20201,468.841,106.99-890.581,685.25
20235,887.50-4,137.30-2,686.10-935.90
20234,959.33-7,943.682,376.07-608.28
The cash flow from Operating Activities of Suven Life Science is -128 as of 2/26/2024